TITLE

Effects of Statins on Renal Function

AUTHOR(S)
Agarwal, Rajiv
PUB. DATE
November 2007
SOURCE
Mayo Clinic Proceedings;Nov2007, Vol. 82 Issue 11, p1381
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Patients with chronic kidney disease (CKD) are much more likely to die of cardiovascular disease than end-stage renal disease. Dysilpidemia is highly prevalent in patients with CKD and may contribute to the elevated cardiovascular risk as well as CKD progression. Statins are lipid-lowering drugs that appear to protect the kidneys via cholesterol reduction as well as noncholesterol-mediated mechanisms. Subgroup analyses of major clinical studies and meta-analyses of smaller trials indicate that statin therapy slows the decline of the giomerular filtration rate. Additionally, statins appear to reduce proteinuria in patients with CKD. Statins are well recognized to reduce cardiovascular morbidity and mortality in patients with and without documented cardiovascular disease and in certain high-risk populations, such as persons with diabetes mellitus. However, conclusive evidence for improved cardiovascular outcomes with statin therapy for CKD is not yet available. Several ongoing studies are evaluating the effect of statins on cardiovascular end points in patients with CKD and may provide data needed to support adjunctive use of these agents in this high-risk population.
ACCESSION #
27392236

 

Related Articles

  • Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. Hallan, Stein I.; Dahl, Ketil; Oien, Cecilia M.; Grootendorst, Diana C.; Aasberg, Arne; Holrnen, Jostein; Dekker, Friedo W. // BMJ: British Medical Journal (International Edition);11/18/2006, Vol. 333 Issue 7577, p1047 

    Objective: To find an effective screening strategy for detecting patients with chronic kidney disease and to describe the natural course of the disease. Design: Eight year follow-up of a cross sectional health survey (the HUNT II study). Setting: Nord-Trøndelag County, Norway Participants: 65...

  • Epidemiology of dyslipidemia in chronic kidney disease. Iseki, Kunitoshi // Clinical & Experimental Nephrology;Apr2014, Vol. 18 Issue 2, p185 

    Dyslipidemia is an established risk factor for atherosclerotic disease, such as stroke and ischemic heart disease, and is often detected in patients with chronic kidney disease (CKD). The role of dyslipidemia in CKD progression, however, is not well understood. CKD patients are heterogeneous and...

  • Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study. Gayoso-Diz, Pilar; Otero-González, Alfonso; Rodríguez-Álvarez, M. Xosé; García, Fernando; González-Quintela, Arturo; Martín-de Francisco, Ángel L. // Nefrologia;2013, Vol. 33 Issue 2, p223 

    Background: Although the prevalence of chronic kidney disease (CKD) is 10-14%, several prospective studies note a low rate of progression to end-stage renal disease (ESRD) in stages 3 and 4. A correct classification of risk of progression, based on demonstrated predictive factors, would allow...

  • Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study. Gayoso-Diz, Pilar; Otero-González, Alfonso; Rodríguez-Álvarez, M. Xosé; García, Fernando; González-Quintela, Arturo; Martín-de Francisco, Ángel L. // Nefrologia;2013, Vol. 33 Issue 2, p223 

    Background: Although the prevalence of chronic kidney disease (CKD) is 10-14%, several prospective studies note a low rate of progression to end-stage renal disease (ESRD) in stages 3 and 4. A correct classification of risk of progression, based on demonstrated predictive factors, would allow...

  • CKD. Doyle, Matt // Pulse;2/1/2007, Vol. 67 Issue 4, p55 

    The article focuses on the medical research on patients with chronic kidney disease (CKD), conducted by renal services national service for the routine reporting of estimated glomerular filtration rate. The patients' population recommends a practice with 10,000 patients will be prone to have...

  • Cardiovascular risk factors in chronic kidney disease. Menon, Vandana; Gul, Ambreen; Sarnak, Mark J. // Kidney International;Oct2005, Vol. 68 Issue 4, p1413 

    Discusses the identification of cardiovascular disease as the primary cause of morbidity and premature mortality in chronic kidney disease. Stages of chronic kidney disease; Rate of fatal and nonfatal cardiovascular events; Inclusion of reduced glomerular filtration rate and microalbuminuria.

  • Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Wen, Chi Pang; Matsushita, Kunihiro; Coresh, Josef; Iseki, Kunitoshi; Islam, Muhammad; Katz, Ronit; McClellan, William; Peralta, Carmen A; Wang, HaiYan; de Zeeuw, Dick; Astor, Brad C; Gansevoort, Ron T; Levey, Andrew S; Levin, Adeera // Kidney International;Oct2014, Vol. 86 Issue 4, p819 

    Some suggest race-specific cutpoints for kidney measures to define and stage chronic kidney disease (CKD), but evidence for race-specific clinical impact is limited. To address this issue, we compared hazard ratios of estimated glomerular filtration rates (eGFR) and albuminuria across races...

  • Ancianos con enfermedad renal crónica: ¿qué ocurre a los cinco años de seguimiento? Heras, Manuel; Fernández-Reyes, M. José; Sánchez, Rosa; Guerrero, M. Teresa; Molina, Álvaro; Rodríguez, M. Astrid; Álvarez-Ude, Fernando // Nefrologia;2012, Vol. 32 Issue 3, p300 

    Introduction: In recent years, chronic kidney disease (CKD) has come to be considered an epidemic problem, and there is considerable interest in early diagnosis in order to slow its progression to End-Stage Renal Disease (ESRD) and prepare patients for dialysis and transplantation programmes....

  • Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. De Cosmo, Salvatore; Rossi, Maria Chiara; Pellegrini, Fabio; Lucisano, Giuseppe; Bacci, Simonetta; Gentile, Sandro; Ceriello, Antonio; Russo, Giuseppina; Nicolucci, Antonio; Giorda, Carlo; Viazzi, Francesca; Pontremoli, Roberto // Nephrology Dialysis Transplantation;Mar2014, Vol. 29 Issue 3, p657 

    Background Kidney dysfunction is a strong predictor of end-stage renal disease and cardiovascular (CV) events. The main goal was to study the clinical correlates of diabetic kidney disease in a large cohort of patients with type 2 diabetes mellitus (T2DM) attending 236 Diabetes Clinics in Italy....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics